New Health Technologies

Managing Access, Value and Sustainability

image of New Health Technologies

This report discusses the need for an integrated and cyclical approach to managing health technology in order to mitigate clinical and financial risks, and ensure acceptable value for money. The analysis considers how health systems and policy makers should adapt in terms of development, assessment and uptake of health technologies. The first chapter provides an examination of adoption and impact of medical technology in the past and how health systems are preparing for continuation of such trends in the future. Subsequent chapters examine the need to balance innovation, value, and access for pharmaceuticals and medical devices, respectively, followed by a consideration of their combined promise in the area of precision medicine. The final chapter examines how health systems can make better use of health data and digital technologies. The report focuses on opportunities linked to new and emerging technologies as well as current challenges faced by policy makers, and suggests a new governance framework to address these challenges.




Technology has been a dominant force in health and medicine, contributing to longer and healthier lives for many people. An early milestone is the aseptic technique, devised in the 19th century, which dramatically reduced avoidable deaths. Antibiotics and vaccines remain, to this day, among the most successful health technologies. Since then, medicine has been strongly associated with technological progress, as a visit to any modern clinic, pharmacy or hospital confirms. Some technologies – insulin, for example, or treatment for heart attacks and stroke – have been remarkably valuable. Others, however, have delivered fewer gains.


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error